Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Improve Osteoporosis by Inhibiting Osteoblasts Apoptosis
-
Published:2019-07-01
Issue:7
Volume:9
Page:1003-1007
-
ISSN:2157-9083
-
Container-title:Journal of Biomaterials and Tissue Engineering
-
language:en
-
Short-container-title:j biomater tissue eng
Author:
Liu Wei,Zhang Bin,Xiao Yan,Liu Qiang,Yan Zhiqiang,Li Bei,Huang Ruiliang,Ou Guangpeng,Deng Songyun,Xu Shaoyong
Abstract
Osteoporosis (OP) is a metabolic bone disease which is characterized by loss of bone mineral content, decreased bone density, destruction of bone microstructure, and declined bone biomechanical evaluation index. In recent years, it was shown that bone marrow mesenchymal stem cells (MSCs)
are involved in the form of exosomes, which has become a hot spot in the research of the pathogenesis of metabolic diseases. In this study, we intend to explore the effects of exosomes derived from MSCs on osteoblast apoptosis and OP. MSC-derived exosomes were obtained by ultracentrifugation
and characterized by transmission electron microscopy (TEM). Exosomes were used to treat osteoblasts to observe cell apoptosis. The expression of apoptosis-related protein was detected by Western blot. Cell viability was examined by MTT assay. Cell apoptosis was assessed by TUNEL staining.
TEM confirmed successfully extracted MSCs-derived exosomes. Exosomes intervention significantly reduced the expression of apoptosis-related pro-apoptotic proteins cytochrome c and caspase3, enhanced cell viability, and attenuated cell apoptosis in osteoblasts. MSCs-derived exosomes can inhibit
osteoblasts apoptosis by suppressing apoptosis signaling pathways, thus improving osteoporosis, indicating that they might be used for the treatment of osteoporosis.
Publisher
American Scientific Publishers
Subject
Biomedical Engineering,Medicine (miscellaneous),Bioengineering,Biotechnology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献